SelectScience InterviewsDrug discovery > Lead Discovery
A mid-down strategy for the mass spectrometric sequencing of progressively larger nucleic acids
29 Nov 2022![A mid-down strategy for the mass spectrometric sequencing of progressively larger nucleic acids A mid-down strategy for the mass spectrometric sequencing of progressively larger nucleic acids](https://cdn.sanity.io/images/f5b6mtfn/selectscience-prod/be2b9952b61c4f4348e87dad68882e6d6a44820f-805x450.jpg?w=3840&q=75&fit=clip&auto=format)
Watch this presentation by Dr. Dan Fabris, Harold S. Schwenk Sr. Distinguished Chair in Chemistry, University of Connecticut, titled: A mid-down strategy for the mass spectrometric sequencing of progressively larger nucleic acids. This talk was presented at the SelectScience® Virtual Biopharmaceuticals Summit 2022.